ResearcherOgaki Municipal HospitalNo recent work listed
Tomoaki Yoshimura
Matched on ORCID iD 0009-0008-2486-8169; OpenAlex author ID A5013340536.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 2 (first author 0, last author 1)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 4
2016: 1 paper · 2017: 1 paper
Papers 2
- Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment of metastatic pancreatic cancer. Last author DOI 10.3892/mco.2017.1278↗
- Neutropenia as a prognostic factor and safety of second-line therapy with S-1 for advanced or recurrent pancreatic cancer. Co-author DOI 10.3892/mco.2016.940↗
Closest collaborators
The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Eiseki Usami · 2 shared papers, 2016–2017
- Paper Comparing the cost-effectiveness of FOLFIRINOX, nab-paclitaxel plus gemcitabine, gemcitabine and S-1 for the treatment … DOI 10.3892/mco.2017.1278↗
- Paper Neutropenia as a prognostic factor and safety of second-line therapy with S-1 for advanced or recurrent pancreatic canc… DOI 10.3892/mco.2016.940↗
- Machiko Kurimoto · 1 shared paper, 2017
- Kimio Yasuda · 1 shared paper, 2016
- Makiko Ikagawa · 1 shared paper, 2016
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.